| Ytd | -57.63% | |
| 1y | -80.57% |
| Open | 1.38 | Prev Close | 1.38 | Low | 1.36 | High | 1.43 | Mkt Cap | 4.14M |
| Vol | 109.02K | Avg Vol | 3.00M | EPS | -7.47 | P/E | N/A | Forward P/E | -0.37 |
| Beta | 0.56 | Short Ratio | 0.02 | Inst. Own | 6.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.77 | 200-d Avg | 3.70 | 1yr Est | 12.00 |
PRF Technologies Ltd. (Nasdaq: PRFX) ("PRF" or the "Company"), a clinical-stage spec
Additional data reported by an independent research firm show comparable analgesic efficacy to ZYNRE
On June 18, 2026, PRF Technologies Ltd. (the "Company") entered into a Standby Equity Purcha
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
PRF Technologies (NASDAQ:PRFX) stock falls sharply Monday morning. Read why analysts see this as a m
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce